Santosh J. Vetticaden

2018 - DepoMed

In 2018, Santosh J. Vetticaden earned a total compensation of $1.1M as Former Senior Vice President and Chief Medical Officer at DepoMed, a 58% increase compared to previous year.

Compensation breakdown

Salary$158,336
Stock Awards$621,184
Other$307,389
Total$1,086,909

Vetticaden received $621.2K in stock awards, accounting for 57% of the total pay in 2018.

Vetticaden also received $158.3K in salary and $307.4K in other compensation.

Rankings

In 2018, Santosh J. Vetticaden's compensation ranked 8,808th out of 14,244 executives tracked by ExecPay. In other words, Vetticaden earned more than 38.2% of executives.

ClassificationRankingPercentile
All
8,808
out of 14,244
38th
Division
Manufacturing
3,508
out of 5,765
39th
Major group
Chemicals And Allied Products
1,328
out of 2,128
38th
Industry group
Drugs
1,112
out of 1,817
39th
Industry
Pharmaceutical Preparations
865
out of 1,391
38th
Source: SEC filing on April 8, 2019.

Vetticaden's colleagues

We found six more compensation records of executives who worked with Santosh J. Vetticaden at DepoMed in 2018.

2018

Arthur Higgins

DepoMed

Chief Executive Officer

2018

Stanley Bukofzer

DepoMed

Senior Vice President and Chief Scientific and Technical Officer

2018

Phillip Donenberg

DepoMed

Chief Financial Officer

2018

August Moretti

DepoMed

Chief Financial Officer

2018

Matthew Gosling

DepoMed

General Counsel

2018

Daniel Peisert

DepoMed

Chief Financial Officer

News

You may also like